Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma, Ewing 2Vaginal Neoplasms 1Stomach Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oropharyngeal Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Ganglioneuroblastoma 1Cholangiocarcinoma 1Carcinosarcoma 1Carcinoma, Hepatocellular 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 24Fluorouracil 20Capecitabine 16pembrolizumab 15Nivolumab 15Leucovorin 13Trastuzumab 9fludarabine 8Paclitaxel 8Drug Therapy 8Docetaxel 8Cyclophosphamide 8S 1 (combination) 7trastuzumab deruxtecan 6Specimen Handling 6Cisplatin 6Magnetic Resonance Spectroscopy 5Bevacizumab 5zolbetuximab 4Irinotecan 4Biopsy 4zimberelimab 3sintilimab 3fludarabine phosphate 3atezolizumab 3aldesleukin 3XELOX 3Surgical Procedures, Operative 3Ramucirumab 3Radiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Congresses as Topic × 90 days × Clear all
NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡